Jaypirca

Active Ingredient(s): Pirtobrutinib
FDA Approved: * January 27, 2023
Pharm Company: * LOXO ONCOL
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Jaypirca 50 mg Oral Tablet, Coated
NDC: 0002-6902
Labeler:
Eli Lilly and Company
Jaypirca 100 mg Oral Tablet, Coated
NDC: 0002-7026
Labeler:
Eli Lilly and Company